Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Cancer (CCA)”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Not applicableNot Yet RecruitingNCT07454486
What this trial is testing

TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

Who this might be right for
Biliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Gall Bladder Cancer+11 more
Aarhus University Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT07135544
What this trial is testing

A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerBiliary Tract Cancer (CCA)
Yongjun Chen 37
Testing effectiveness (Phase 2)Study completedNCT03230318
What this trial is testing

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Basilea Pharmaceutica 148
Early research (Phase 1)Study completedNCT01900158
What this trial is testing

A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas

Who this might be right for
Cholangiocarcinoma
PCI Biotech AS 24
Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Not applicableEnded earlyNCT02908048
What this trial is testing

Extracellular RNA Markers of Liver Disease and Cancer

Who this might be right for
Hepatocellular CarcinomaBiliary Tract CancerCirrhosis+1 more
Mayo Clinic 1,865
Early research (Phase 1)Study completedNCT04853017
What this trial is testing

ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

Who this might be right for
Minimal Residual DiseaseKRAS G12DKRAS G12R+9 more
Elicio Therapeutics 25
Not applicableStudy completedNCT03041662
What this trial is testing

Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)

Who this might be right for
Primary Sclerosing CholangitisCholangiocarcinoma
Karolinska University Hospital 620
Testing effectiveness (Phase 2)Study completedNCT03473574
What this trial is testing

Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients

Who this might be right for
CholangiocarcinomaGall Bladder CarcinomaCholangiocarcinoma Non-resectable+1 more
AIO-Studien-gGmbH 128
Not applicableLooking for participantsNCT07206355
What this trial is testing

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

Who this might be right for
Biliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Cholangiocarcinoma+4 more
University of Nottingham 160
Testing effectiveness (Phase 2)Ended earlyNCT04099888
What this trial is testing

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer

Who this might be right for
Cholangiocarcinoma
PCI Biotech AS 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06569225
What this trial is testing

Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA

Who this might be right for
Cholangiocarcinoma Resectable
University Health Network, Toronto 40
Not applicableUnknownNCT01549795
What this trial is testing

Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy

Who this might be right for
Hilar CholangiocarcinomaPrimary Sclerosing Cholangitis
Azienda Ospedaliera di Padova 33
Testing effectiveness (Phase 2)Study completedNCT02181634
What this trial is testing

Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
PrECOG, LLC. 74
Large-scale testing (Phase 3)Ended earlyNCT02082522
What this trial is testing

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Who this might be right for
Hilar Cholangiocarcinoma
Concordia Laboratories Inc. 28
Testing effectiveness (Phase 2)Looking for participantsNCT04645160
What this trial is testing

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Who this might be right for
CholangiocarcinomaBile Duct NeoplasmBiliary Tract Malignancy
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT05239169
What this trial is testing

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (CCA)Intrahepatic CholangiocarcinomaHilar Cholangiocarcinoma+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 40